PMS and PMDD share a timing pattern — symptoms in the one to two weeks before a period that lift within days of bleeding starting — but they differ in severity, in diagnostic rules, and in treatment. Up to three in four menstruating women experience some premenstrual symptoms, per the American College of Obstetricians and Gynecologists, while premenstrual dysphoric disorder affects an estimated 2 to 10 percent, per ACOG. The dividing line: PMDD requires at least one core mood symptom — marked depression, anxiety, mood swings, or anger — severe enough to interfere with work, school, or relationships, per the diagnostic criteria in the DSM-5, the manual US psychiatrists use.
This site publishes information, not medical advice. Severe premenstrual mood symptoms respond to real treatment, so this comparison is a reason to book a visit, not a verdict.
What exactly counts as PMS?
PMS is a cluster of physical and emotional symptoms during the luteal phase, the one to two weeks after ovulation, per ACOG. The physical side includes bloating, breast tenderness, headaches, acne flare-ups, and food cravings; the emotional side includes irritability, tearfulness, and trouble concentrating. More than 150 symptoms have been described in the literature, per ACOG's practice bulletin, which is part of why the condition was historically dismissed. What defines PMS is the rhythm, not any single symptom: symptoms build after ovulation, peak just before bleeding, and resolve within about four days of the period starting — then repeat month after month.
How is PMDD different from severe PMS?
PMDD is a distinct diagnosis, not a synonym for bad PMS, and the difference sits in the mood domain. Per the DSM-5 criteria, PMDD requires at least five symptoms in the week before menses, including at least one of four core mood symptoms: marked affective lability, marked irritability or anger, marked depressed mood with feelings of hopelessness, or marked anxiety. The physical symptoms of PMS may be present, but they are not the center of the picture. Many women with PMDD describe functioning normally for two weeks, then losing whole weeks to despair, rage, or anxiety that arrives like clockwork — the predictability is a diagnostic clue, not a character flaw. Researchers link PMDD to an abnormal sensitivity to normal hormonal fluctuations: a 2017 study in Molecular Psychiatry found women with PMDD showed altered gene expression in response to estrogen and progesterone, suggesting their cells, not their hormones, react differently.
How is the diagnosis actually made?
With a diary, not a memory. Both ACOG and the DSM-5 require prospective daily symptom ratings across at least two menstrual cycles to confirm either diagnosis, because retrospective recall exaggerates both severity and timing. Free validated tools, such as the Daily Record of Severity of Problems, let you rate mood, physical symptoms, and interference each evening. The diagnosis is confirmed when symptoms cluster in the luteal phase and remit after menses in both recorded cycles; symptoms present every day of the month point instead toward depression, anxiety, or another condition that needs its own treatment.
Related stories: When to Start Mammograms: What the Major Guidelines Say in 2026 · Always Tired? The Most Common Causes of Constant Fatigue in Women.
What treatments have evidence?
For PMS, evidence supports regular aerobic exercise, calcium supplementation at 1,000 to 1,200 mg per day, and limiting salt, caffeine, and alcohol, per ACOG — modest measures with modest effects. For PMDD, the evidence steps up: selective serotonin reuptake inhibitors are the best-studied treatment, effective both taken daily and taken only during the luteal phase, and two SSRIs — fluoxetine and sertraline — are FDA-approved specifically for PMDD, per ACOG. Hormonal options that suppress ovulation, including combined oral contraceptives containing drospirenone, carry an FDA indication for PMDD as well. Cognitive behavioral therapy has trial support for both conditions, and a 2020 review in the Journal of Affective Disorders found CBT improved premenstrual mood symptoms beyond waiting-list controls. Vitamin B6 and evening primrose oil remain popular, but evidence for the latter is weak, and B6 doses above 100 mg per day carry nerve-toxicity risk, per the NIH Office of Dietary Supplements.
Why did it take so long for PMDD to be taken seriously?
History explains some of the skepticism women still feel. PMDD entered the DSM-5 in 2013 as a depressive disorder, but researchers had been documenting cyclical mood impairment since the 1980s, and the 2017 Molecular Psychiatry findings finally supplied a biological signature — altered transcription of genes governing hormone and stress response in lymphoblastoid cell lines. In other words, the cells of women with PMDD respond to normal hormone cycles differently, which supports what patients have reported for decades: the suffering is real, cyclical, and rooted in biology, not fragility or attitude. Naming it was what unlocked insurance coverage, dedicated research funding, and the FDA approvals that today give PMDD its unusually strong treatment evidence.
When to talk to a clinician
Bring up the topic if premenstrual symptoms routinely damage relationships, derail work, or bring thoughts of self-harm — the last one is urgent and deserves same-week care. Start a daily diary now and book a visit after two full cycles; the record is the single most useful thing you can carry into the appointment. Ask specifically about PMDD if your worst days are mood days, and about SSRI options taken only in the second half of the cycle if daily medication does not appeal to you.
The bottom line
PMS is common, affecting up to three in four menstruating women, while PMDD affects roughly 2 to 10 percent and is defined by severe mood symptoms that impair functioning, per ACOG and DSM-5 criteria. The diagnosis of both depends on a prospective two-cycle symptom diary, and PMDD has well-studied treatments, including FDA-approved SSRIs. Track two cycles, take the record to a clinician, and treat severe premenstrual mood symptoms as the medical condition they are.